MYRIAD GENETICS
Over a 17-year career helped to lead and transform the company from an early-stage pioneer in molecular diagnostics with $14M annual revenue, 300 employees, and 1 product to the largest and only profitable global precision medicine company with $790M in annual revenue, 2,800 employees, and 11 products.
